When was Shaanxi Micot Technology founded?

Shaanxi Micot Technology was founded in 2007 and raised its 1st funding round 12 years after it was founded.

Where is Shaanxi Micot Technology located?

Shaanxi Micot Technology is headquartered in China.

How many employees does Shaanxi Micot Technology have?

As of Aug 31, 2026, the latest employee count at Shaanxi Micot Technology is 11.

Is Shaanxi Micot Technology a funded company?

Shaanxi Micot Technology is a funded company, having raised a total of $72.2M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Oct 16, 2019.

When was the latest funding round of Shaanxi Micot Technology?

Shaanxi Micot Technology's latest funding was a $***** Series B round on May 21, 2021, with participation from 1 investor.

Where does Shaanxi Micot Technology rank among its competitors?

Shaanxi Micot Technology ranks 4th amongst 77 active competitors, of which 6 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Enzene, which secured $50M in Jan, 2023.

Who are the top competitors of Shaanxi Micot Technology?

Shaanxi Micot Technology's top competitors include AmbioPharm, Enzene and PolyPeptide. Among them, Enzene secured the most recent funding round in January, 2023.

Shaanxi Micot Technology - 2026 Company Profile, Team, Funding & Competitors

Company Details

Website: micot.cn
Email ID: *****@micot.cn
Phone Number: +86 **********

Key Metrics

Founded Year

2007

Location

China

Stage

Public

Total Funding

$72.2M in 2 rounds

Latest Funding Round

Series B, May 21, 2021, $*****

Investors

NLVC & 3 more

Ranked

4^th among 77 active competitors

Employee Count

11 as on Aug 31, 2026

Similar Companies

AmbioPharm & 85 more

Exit Details

Public

View Shaanxi Micot Technology's full profile

Shaanxi Micot Technology got listed on Jun 24, 2026.

Click here to take a look at Shaanxi Micot Technology's IPO in detail

Shaanxi Micot Technology has raised a total funding of $72.2M over 2 rounds. Its first funding round was on Oct 16, 2019. Its latest funding round was a Series B round on May 21, 2021 for $*****. 1 investor participated in its latest round. Shaanxi Micot Technology has 4 institutional investors.

Here is the list of recent funding rounds of Shaanxi Micot Technology:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 21, 2021	1255729	Series B	4010224	7945202	6746468	2781434
Oct 16, 2019	3770161	Seed	6125062	8595893	NLVC	Tasly & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Shaanxi Micot Technology's funding rounds and investors

The founders of Shaanxi Micot Technology is Wang Bing.

Here are the details of Shaanxi Micot Technology's key team members:

Wang Bing: Founder Chairman & President of Shaanxi Micot Technology.

View details of Shaanxi Micot Technology's Founder profiles and Board Members

Shaanxi Micot Technology's employee count trend

Shaanxi Micot Technology has 11 employees as of Aug 26. Here is Shaanxi Micot Technology's employee count trend over the years:

Employee count trend for Shaanxi Micot Technology

Uncover Shaanxi Micot Technology's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Shaanxi Micot Technology include AmbioPharm, Enzene and PolyPeptide. Here is the list of Top 10 competitors of Shaanxi Micot Technology, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AmbioPharm 2006, North Augusta (United States), Acquired	Peptide manufacturing and development services, setting a new standard worldwide	$24M	The Carlyle Group, MVM & 1 others	58/100
2nd	Enzene 2015, Pune (India), Series C	Company specializing in development of Biosimilars	$50M	F-Prime Capital, Eight Roads Ventures & 1 others	55/100
3rd	PolyPeptide 1952, Baar (Switzerland), Public	CMO manufacturing proprietary,GMP grade and non-GMP-grade peptides	-	-	49/100
4th	Shaanxi Micot Technology 2007, China, Public	Provider of drug research and development services focused on cardiovascular and metabolic diseases	$72.2M	NLVC, Tasly & 2 others	49/100
5th	Hybio Pharmaceutical 1998, Shenzhen (China), Public	Developer and manufacturer of polypeptide drugs and APis	$15M	Shenzhen Capital Group, SAIF Partners & 1 others	43/100
6th	JPT Peptide 2004, Berlin (Germany), Acquired	Peptide based CRO offering proteomics, biomarker and drug discovery services	-	-	40/100
7th	Peptidesynthesis.co.in 2011, India, Unfunded	Manufacturer of peptides and other finished formulations, & APIs	-	-	40/100
8th	Proteos Biotech 2010, Madrid (Spain), Unfunded	Manufacturer of recombinant enzymes and provides CMO services	-	-	38/100
9th	Rameda 1994, Giza (Egypt), Public	Developer and manufacturer of generic pharmaceuticals, nutraceuticals, food supplements and veterinary products	-	Public Investment Fund, Compass Capital	37/100
10th	CPC Scientific 2001, Sunnyvale (United States), Unfunded	Company offering peptide development and manufacturing services for clinical and commercial applications	-	-	36/100